Mark W. Lingen

University of Chicago

Papers

2

Total Citations

57

H-Index

2

About

No biography available yet.

Research Focus

Oncology2 · 57 citations
Cancer2 · 57 citations
Complete response2 · 57 citations
Immunotherapy2 · 57 citations
Internal medicine2 · 57 citations
Medicine2 · 57 citations
Chemotherapy2 · 57 citations
Nivolumab1 · 45 citations
Breast cancer1 · 45 citations
Neoadjuvant therapy1 · 45 citations
Cancer research1 · 12 citations

Key Achievements

2
H-Index
2
Papers
57
Total Citations
29
Avg Citations/Paper
🏆 Most Cited Paper
Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV<sup>+</sup> Oropharyngeal Cancer
45 citations · 2024
📈 Most Prolific Year: 2024 (2 Papers)
🤝 Key Collaborators: 25
🏛 Institutions: University of Chicago

Top Papers

  1. 1
    Neoadjuvant Nivolumab Plus Chemotherapy Followed By Response-Adaptive Therapy for HPV<sup>+</sup> Oropharyngeal Cancer
    45 citations · 2024
  2. 2
    Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV.
    12 citations · 2024

Key Collaborators

EEEverett E. Vokes2 shared papersNANicole A. Cipriani2 shared papersATAlexander T. Pearson2 shared papersAJAri J. Rosenberg2 shared papersJCJohn Cursio2 shared papersEAElizabeth A. Blair2 shared papersNANishant Agrawal2 shared papersDJDaniel J. Haraf2 shared papersASAnna Starus2 shared papersZGZhen Gooi2 shared papersRHRifat Hasina2 shared papersAJAditya Juloori2 shared papersEIEvgeny Izumchenko2 shared papersJCJeffrey Chin1 shared papersCPChristopher Plescia1 shared papersRRRohan Reddy Katipally1 shared papersFSFrederick S. Jones1 shared papersEMEllen MacCracken1 shared papersFRF. R. Jones1 shared papersDTDaniel Thomas Ginat1 shared papers
Not generated yet